MedTrace Logo

Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

NCT02593942 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-11-02

No results posted yet for this study

Summary

Total intravenous anaesthesia using propofol and remifentanil are routinely used drugs for this purpose. The hemodynamic stability and at the same time early emergency are the main goals following neurosurgery. However there is no standard for discontinuation time for manually controlled systems today.

The investigators aimed to study the effect of remifentanil infusion alone for early emergence and hemodynamic stability during the closure period in patients undergoing supratentorial craniotomy.

Conditions

  • Supratentorial Neoplasms

Interventions

DRUG

Remifentanil

0.1-0.5 mcg/kg/min infusion

DRUG

Propofol

75-200 mcg/kg/min infusion

Sponsors & Collaborators

  • Yeditepe University Hospital

    lead OTHER

Principal Investigators

  • Hatice Ture, MD. · Yeditepe University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593942 on ClinicalTrials.gov